Canada markets open in 8 hours 49 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.69+0.69 (+4.06%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close17.00
Bid0.00 x 1100
Ask0.00 x 1800
Day's Range16.50 - 18.45
52 Week Range1.92 - 33.79
Avg. Volume35,016,428
Market Cap2.963B
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-1.85
Earnings DateAug. 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.00
  • Why Inovio Stock Is Bouncing Back Today
    Motley Fool

    Why Inovio Stock Is Bouncing Back Today

    Shares of Inovio Pharmaceuticals (NASDAQ: INO) were bouncing back somewhat on Friday after Thursday's sharp decline. It's also possible that some short-sellers could be covering their positions before the weekend as a precaution in case Inovio announces good news before Monday. There seems to be a good chance that Inovio will have positive news to announce in the near future.

  • Why Inovio Pharmaceuticals Is Losing Steam Today
    Motley Fool

    Why Inovio Pharmaceuticals Is Losing Steam Today

    Shares of the developmental vaccine and immunotherapy company Inovio Pharmaceuticals (NASDAQ: INO) fell by as much as 15.8% right out of the gate Thursday morning. Investors seemingly piled into this biotech stock this week in the hopes of getting in before the company lands a large grant for its COVID-19 vaccine candidate, INO-4800. Not everyone was impressed by Inovio's investor presentation, however.

  • Yahoo Finance Video

    Cos. with a real vaccine history will have their data sets in early 2021: Expert

    Jared Holz, Healthcare Equity Strategist at Jefferies, weighs in on the latest coronavirus vaccine developments, as President Trump states in an interview that a COVID-19 vaccine may be ready in four weeks.